Last synced on 21 February 2025 at 11:05 pm

Endovascular System For Treatment Of Thoracoabdominal And Pararenal Aortic Lesions

Page Type
Product Code
Definition
Endovascular repair of thoracoabdominal and pararenal aortic lesions
Physical State
The endovascular system is a metal scaffold which may or may not be covered with fabric material. The permanent implant is placed via a delivery catheter into the aorta and its branching vessels.
Technical Method
An endovascular procedure in which a single component or multiple components of the device system are delivered into the aorta and branching vessels via catheters inserted through small incisions in the arteries of the arm and leg. These components redirect blood flow to treat the lesion.
Target Area
Segment of the aorta bridging across the diaphragm from the chest through the abdomen involving the renal arteries and visceral branch vessels. More proximal and/or more distal anatomy may also be involved.
Review Panel
Cardiovascular
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QZK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Endovascular System For Treatment Of Thoracoabdominal And Pararenal Aortic Lesions

Page Type
Product Code
Definition
Endovascular repair of thoracoabdominal and pararenal aortic lesions
Physical State
The endovascular system is a metal scaffold which may or may not be covered with fabric material. The permanent implant is placed via a delivery catheter into the aorta and its branching vessels.
Technical Method
An endovascular procedure in which a single component or multiple components of the device system are delivered into the aorta and branching vessels via catheters inserted through small incisions in the arteries of the arm and leg. These components redirect blood flow to treat the lesion.
Target Area
Segment of the aorta bridging across the diaphragm from the chest through the abdomen involving the renal arteries and visceral branch vessels. More proximal and/or more distal anatomy may also be involved.
Review Panel
Cardiovascular
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QZK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.